XORTX Therapeutics Inc. filed a 6-K with the SEC on September 6, 2024, confirming its status as a foreign private issuer and plans to file annual reports under Form 20-F.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.